Ashe Andrew D. 4
4 · Verve Therapeutics, Inc. · Filed May 15, 2024
Insider Transaction Report
Form 4
Ashe Andrew D.
See Remarks
Transactions
- Purchase
Common Stock
2024-05-14$6.26/sh+76,000$475,760→ 342,509 total
Footnotes (1)
- [F1]Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $6.22 to $6.30 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.